Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
USA116th CongressHRES-242| House
| Updated: 3/19/2019
G. K. Butterfield
Democratic Representative
North Carolina
Cosponsors (6)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Congressional tributesDrug safety, medical device, and laboratory regulationDrug therapyHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth promotion and preventive careMedical researchPrescription drugsResearch and development
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
USA116th CongressHRES-242| House
| Updated: 3/19/2019
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
G. K. Butterfield
Democratic Representative
North Carolina
Cosponsors (6)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional tributesDrug safety, medical device, and laboratory regulationDrug therapyHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth promotion and preventive careMedical researchPrescription drugsResearch and development